Results 191 to 200 of about 26,374,183 (352)
Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla +10 more
wiley +1 more source
Traces of prior art. An analysis of non-patent references found in patent documents. [PDF]
Research in the area of innovation has pointed out the relevance of conceiving innovation as processes in which a multitude of actors and a variety of interactions play a role.
Callaert, J +4 more
core
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff +11 more
wiley +1 more source
Polysaccharide-Based Drug Carriers-A Patent Analysis. [PDF]
Ilić-Stojanović S +3 more
europepmc +1 more source
Reaping What You Sow: An Empirical Analysis of International Patent Harmonization. [PDF]
This paper extends analysis of the GATT Uruguay Round qualifiying the impact of international patent harmonization as implied by the TRIPs agreement.PROPERTY RIGHTS ; INTERNATIONAL ...
McCalman, P.
core
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala +15 more
wiley +1 more source
The History and Prediction of Prebiotics and Postbiotics: A Patent Analysis. [PDF]
Zang T +9 more
europepmc +1 more source
Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung +17 more
wiley +1 more source
Revealing Chemical Trends: Insights from Data-Driven Visualization and Patent Analysis in Exposomics Research. [PDF]
Aurich D +4 more
europepmc +1 more source

